63539-016-02 |
63539-016 |
HUMAN PRESCRIPTION DRUG |
XELJANZ |
tofacitinib |
TABLET, FILM COATED |
ORAL |
20180702 |
N/A |
NDA |
NDA203214 |
U.S. Pharmaceuticals |
TOFACITINIB CITRATE |
10 mg/1 |
60 TABLET, FILM COATED in 1 BOTTLE (63539-016-02) |
63539-012-02 |
63539-012 |
HUMAN PRESCRIPTION DRUG |
XELJANZ |
tofacitinib |
TABLET, FILM COATED |
ORAL |
20121108 |
N/A |
NDA |
NDA203214 |
U.S. Pharmaceuticals |
TOFACITINIB CITRATE |
5 mg/1 |
60 TABLET, FILM COATED in 1 BOTTLE (63539-012-02) |
0069-1002-01 |
0069-1002 |
HUMAN PRESCRIPTION DRUG |
XELJANZ |
tofacitinib |
TABLET, FILM COATED |
ORAL |
20180702 |
N/A |
NDA |
NDA203214 |
Pfizer Laboratories Div Pfizer Inc |
TOFACITINIB CITRATE |
10 mg/1 |
60 TABLET, FILM COATED in 1 BOTTLE (0069-1002-01) |
0069-1001-01 |
0069-1001 |
HUMAN PRESCRIPTION DRUG |
XELJANZ |
tofacitinib |
TABLET, FILM COATED |
ORAL |
20121109 |
N/A |
NDA |
NDA203214 |
Pfizer Laboratories Div Pfizer Inc |
TOFACITINIB CITRATE |
5 mg/1 |
60 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01) |